Dihydroergotamine Mesylate

Rank #485 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$14.4M

Total Cost

Share:

6,855

Total Claims

$14.4M

Total Cost

166

Prescribers

$2,107

Cost per Claim

543

Beneficiaries

7,006

30-Day Fills

$87K

Avg Cost/Provider

41

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$14.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $14.4M total

🔎 Data Overview

💰

At $2,107 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $26,597 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Dihydroergotamine Mesylate

#ProviderSpecialtyLocationClaimsCost
1Vlad NusinovichInternal MedicineWest Hollywood, CA462$1.4M
2Sonia Walker-AdamsonFamily PracticeSt. Albans, NY418$933K
3Maria DolgovinaNeurologyForest Hills, NY306$611K
4Paul CatanzaroInterventional Pain ManagementSaint Louis, MO240$490K
5Mikhail KorogluyevOsteopathic Manipulative MedicineBrooklyn, NY256$473K
6Victoria FeldmanNurse PractitionerStaten Island, NY215$399K
7Ricky LockettPhysical Medicine and RehabilitationSaint Petersburg, FL155$383K
8Marina NeystatNeurologyForest Hills, NY162$284K
9Amaiak ChilingaryanNeurologyGlendale, CA115$247K
10Rozaliya OstrovskayaInternal MedicineBrooklyn, NY113$233K
11Bernadette GuiaNurse PractitionerPanorama City, CA74$217K
12Arkady SternFamily PracticeLos Angeles, CA75$212K
13Ivan MikolaenkoCritical Care (Intensivists)Rockville Centre, NY102$200K
14Yanina RubinshteynFamily PracticeRego Park, NY92$198K
15David KhasidyInternal MedicineBrooklyn, NY85$191K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
482Rasagiline Mesylate (Rasagiline Mesylate)$14.5M47,985
483Pazopanib Hcl (Votrient)$14.5M1,156
484Exemestane (Exemestane)$14.5M66,285
485Dihydroergotamine Mesylate (Dihydroergotamine Mesylate)$14.4M6,855
486Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone)$14.4M503,015
487Verapamil Hcl (Verapamil Er)$14.4M329,950
488Eteplirsen (Exondys-51)$14.4M192

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology